1.0600
+0.0100
+(0.95%)
At close: April 17 at 4:00:02 PM EDT
1.0417
-0.02
(-1.73%)
After hours: April 17 at 4:02:45 PM EDT
Research Analysis
Earnings Estimate
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -0.17 | -0.14 | -0.58 | -0.49 |
| Low Estimate | -0.17 | -0.17 | -0.69 | -0.69 |
| High Estimate | -0.17 | -0.1 | -0.46 | -0.25 |
| Year Ago EPS | -0.17 | -0.24 | -0.78 | -0.58 |
Revenue Estimate
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 4 | 4 |
| Avg. Estimate | 34.33k | 23.33k | 252k | 560.75k |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 55k | 59k | 549k | 1.03M |
| Year Ago Sales | 36.04k | 6.36k | 165.79k | 252k |
| Sales Growth (year/est) | -4.74% | 266.82% | 52.00% | 122.52% |
Earnings History
| Currency in EUR | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.22 | -0.19 | -0.25 | -0.28 |
| EPS Actual | -0.17 | -0.24 | -0.3 | -0.08 |
| Difference | 0.05 | -0.05 | -0.05 | 0.2 |
| Surprise % | 23.60% | -29.73% | -21.62% | 71.43% |
EPS Trend
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.17 | -0.14 | -0.58 | -0.49 |
| 7 Days Ago | -0.17 | -0.14 | -0.58 | -0.49 |
| 30 Days Ago | -0.31 | -0.25 | -1.09 | -0.74 |
| 60 Days Ago | -0.31 | -0.25 | -1.09 | -0.74 |
| 90 Days Ago | -0.31 | -0.25 | -1.09 | -0.74 |
EPS Revisions
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 2 | 3 | 3 |
| Up Last 30 Days | 2 | 2 | 3 | 3 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IFRX | 0.00% | 43.05% | 25.21% | 16.57% |
| S&P 500 | 6.92% | 5.09% | 8.78% | 14.15% |
Upgrades & Downgrades
| Maintains | Guggenheim: Buy to Buy | 3/26/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/21/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/7/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/16/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/20/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/15/2024 |
Related Tickers
NKTX Nkarta, Inc.
1.8100
+3.43%
IMUX Immunic, Inc.
0.9800
+3.98%
BCYC Bicycle Therapeutics plc
7.39
-1.34%
ENTA Enanta Pharmaceuticals, Inc.
5.10
+3.45%
MGNX MacroGenics, Inc.
1.2600
+6.78%
ETNB 89bio, Inc.
6.06
+2.89%
CDTX Cidara Therapeutics, Inc.
19.44
+1.36%
KPTI Karyopharm Therapeutics Inc.
4.9500
+11.99%
ABEO Abeona Therapeutics Inc.
4.8400
-0.21%
ACIU AC Immune SA
1.4800
-1.33%